COCRYSTAL PHARMA, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
COCRYSTAL PHARMA, INC. (COCP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 88.37 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-23.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-23
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 353.22M shares, a 60.03% increase year-over-year.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 97.47K shares, a 69.35% increase year-over-year.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 87.07M shares, a 66.99% increase year-over-year.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 220.72M shares, a 652270.55% increase year-over-year.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 88.37M shares, a 60.04% increase from fiscal 2020.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 55.22M shares, a 173216.80% increase from fiscal 2019.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 31.86K shares, a 13.75% increase from fiscal 2018.
- COCRYSTAL PHARMA, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 28.01K shares, a 99.88% decline from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | 353.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 176.66M shares derived: average of 2 quarters · filed 2022-03-23 | 146.79M shares derived: average of 3 quarters · filed 2022-03-23 | 88.37M shares 10-K · filed 2022-03-23 | |
| 2021-09-30 | 97.47K shares 10-Q · filed 2021-11-15 | 43.58M shares derived: average of 2 quarters · filed 2021-11-15 | 85.30K shares 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | 87.07M shares 10-Q · filed 2021-08-16 | 79.12M shares 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | 220.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | 110.39M shares derived: average of 2 quarters · filed 2022-03-23 | 90.97M shares derived: average of 3 quarters · filed 2022-03-23 | 55.22M shares 10-K · filed 2022-03-23 | 55.22K shares 10-K · filed 2021-03-17 |
| 2020-09-30 | 57.55K shares 10-Q · filed 2021-11-15 | 26.10M shares derived: average of 2 quarters · filed 2021-11-15 | 50.49K shares 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | 52.14M shares 10-Q · filed 2021-08-16 | 46.93M shares 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | 33.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 32.73K shares derived: average of 2 quarters · filed 2021-03-17 | 31.86K shares 10-K · filed 2021-03-17 | ||
| 2019-09-30 | 31.62K shares 10-Q · filed 2020-11-13 | 31.20K shares 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | 28.01K shares 10-K · filed 2020-03-27 | 28.01M shares 10-K · filed 2019-04-01 | |||
| 2017-12-31 | 24.13M shares 10-K · filed 2019-04-01 | ||||
| 2015-03-31 | 439.89M shares 10-Q · filed 2015-05-14 | ||||
| 2014-09-30 | 327.21K shares 10-Q · filed 2014-11-14 | 326.53K shares 10-Q · filed 2014-11-14 | |||
| 2014-03-31 | 32.45M shares 10-Q · filed 2015-05-14 | ||||
| 2013-09-30 | 57.26K shares 10-Q · filed 2014-11-14 | 57.26K shares 10-Q · filed 2014-11-14 | |||
| 2011-12-31 | 50.44M shares 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |